Real-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey.

Autor:	Pingree MJ; Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55901, USA., Hurdle MF; Pain Medicine & Spine Care, Mayo Clinic, Jacksonville, FL 32224, USA., Spinner DA; Rehabilitation Medicine, Mount Sinai Health System, New York, NY 10029, USA., Valimahomed A; Gramercy Pain Center, Holmdel, NJ 07728, USA., Crosby ND; SPR Therapeutics, Cleveland, OH 44122, USA., Boggs JW; SPR Therapeutics, Cleveland, OH 44122, USA.
Jazyk:	angličtina
Zdroj:	Pain management [Pain Manag] 2022 Jul; Vol. 12 (5), pp. 611-621. Date of Electronic Publication: 2022 May 05.
DOI:	10.2217/pmt-2022-0005
Abstrakt:	Objective: This study presents real-world data from a cross-sectional follow-up survey of patients who previously received 60-day peripheral nerve stimulation (PNS) treatment for pain. Materials & methods: A survey including validated pain and other related outcome measures was distributed to patients who previously underwent implantation of temporary PNS leads for 60-day PNS treatment. Results: Among survey respondents who were at least 3 months from the start of treatment, most reported sustained clinically significant improvements in pain and/or quality of life, with the length of follow-up at the time of survey completion ranging from 3 to 30 months. Conclusion: These real-world data support recent prospective studies indicating that 60-day percutaneous PNS provides significant and sustained relief across a wide range of pain conditions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu